News

October 7, 2011 — Among individuals 65 years and older, as many as 30 percent have aortic valve sclerosis or stenosis and, as a result of their deteriorating health, cannot enjoy a normal...

September 20, 2011 — Boston Scientific Corp. has launched its Coyote Balloon Catheter, a highly deliverable and ultra-low profile 0.014-inch balloon dilatation catheter designed to treat patients...

September 15, 2011 – The Cardiovascular Research Foundation (CRF) has announced the late breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular...

September 15, 2011 — Very positive results were reported in the first account of a clinical study evaluating the effectiveness of angioplasty with drug-eluting balloons for critical limb ischemia...

September 9, 2011 — Angioslide Ltd. announced the first procedures with its new 5 x 300 mm Proteus device for treating the superficial femoral artery (SFA). The technology combines a percutaneous...

August 5, 2011 — Vessix Vascular Inc. (formerly known as Minnow Medical Inc.), developer of novel percutaneous radiofrequency (RF) balloon catheter technology for peripheral leg vessels, announced...

July 26, 2011 – The first patient has been enrolled in the LEVANT 2 clinical trial, a global, multi-center, randomized trial evaluating the safety and efficacy of Lutonix’s Moxy drug-coated...

June 20, 2011 — Boston Scientific Corporation today announced the global launch of its Mustang PTA balloon catheter, a highly deliverable 0.035-inch percutaneous transluminal angioplasty (PTA)...
May 24, 2011 - Cordis announced it has obtained CE mark for its Empira and Empira NC RX percutaneous transluminal coronary angioplasty (PTCA) dilatation catheters for the treatment of coronary artery...
May 17, 2011 - Medrad Inc., a business of Bayer HealthCare, today announced it has received CE Mark for its Cotavance Paclitaxel Coated Balloon Angioplasty Catheter with Paccocathtechnology. The...

March 7, 2011 – A pilot study testing a system designed to improve acute coronary syndrome (ACS) revascularization has been successfully completed. The study looked at the Picso Impulse System,...

January 11, 2011 – TriReme Medical has signed an exclusive distribution and sales agreement with Century Medical for the Japanese market. Century Medical will sell TriReme’s compete line of...

December 5, 2010 – Additional lots lots of the AngioSculpt Percutaneous Transluminal Angioplasty (PTA) Scoring Balloon Catheters are being recalled by the AngioScore Inc. The class I recall was...

January 3, 2011 – ev3, a Covidien company, has initiated a voluntary recall of specific lots of the NanoCross .014-inch Over-the-wire (OTW) peripheral transcatheter angioplasty (PTA) dilatation...

December 16, 2010 – A system designed to improve acute coronary syndrome (ACS) revascularization following percutaneous coronary intervention (PCI) has received CE Mark.

November 17, 2010 – A drug-eluting balloon (DEB) and a coronary stent have received CE mark approval in Europe. The DEB and the coronary CoCr stent, both by Blue Medical, have been approved for...

November 5, 2010 – New research shows that novel drug-coated balloon technology is being adopted in niche applications throughout Europe. The research, from the Millenium Research Group, also...

September 29, 2010 – Results from a trial studying the effects of a drug-eluting balloon (DEB) on peripheral artery disease (PAD) were released at the Transcatheter Cardiovascular Therapeutics (...

September 17, 2010 - The Food and Drug Administration (FDA) cleared the first device that combines an angioplasty balloon and an embolic capturing feature. Angioslide's Proteus device is presently...

September 10, 2010 – Cath Labs are being encouraged this week by the U.S. Food and Drug Administration (FDA) to inspect their inventories for AngioSculpt EX Percutaneous Transluminal Coronary...